Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Phosphorylated full-length Tau interacts with 14-3-3 proteins via two short phosphorylated sequences, each occupying a binding groove of 14-3-3 dimer

JF. Neves, O. Petrvalská, F. Bosica, FX. Cantrelle, H. Merzougui, G. O'Mahony, X. Hanoulle, T. Obšil, I. Landrieu

. 2021 ; 288 (6) : 1918-1934. [pub] 20201010

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

E-resources Online Full text

NLK Free Medical Journals from 2005 to 1 year ago
Medline Complete (EBSCOhost) from 2005-01-01 to 1 year ago
Wiley Free Content from 2005 to 1 year ago

Protein-protein interactions (PPIs) remain poorly explored targets for the treatment of Alzheimer's disease. The interaction of 14-3-3 proteins with Tau was shown to be linked to Tau pathology. This PPI is therefore seen as a potential target for Alzheimer's disease. When Tau is phosphorylated by PKA (Tau-PKA), several phosphorylation sites are generated, including two known 14-3-3 binding sites, surrounding the phosphorylated serines 214 and 324 of Tau. The crystal structures of 14-3-3 in complex with peptides surrounding these Tau phosphosites show that both these motifs are anchored in the amphipathic binding groove of 14-3-3. However, in the absence of structural data with the full-length Tau protein, the stoichiometry of the complex or the interface and affinity of the partners is still unclear. In this work, we addressed these points, using a broad range of biophysical techniques. The interaction of the long and disordered Tau-PKA protein with 14-3-3σ is restricted to two short sequences, containing phosphorylated serines, which bind in the amphipathic binding groove of 14-3-3σ. Phosphorylation of Tau is fundamental for the formation of this stable complex, and the affinity of the Tau-PKA/14-3-3σ interaction is in the 1-10 micromolar range. Each monomer of the 14-3-3σ dimer binds one of two different phosphorylated peptides of Tau-PKA, suggesting a 14-3-3/Tau-PKA stoichiometry of 2 : 1, confirmed by analytical ultracentrifugation. These results contribute to a better understanding of this PPI and provide useful insights for drug discovery projects aiming at the modulation of this interaction.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026009
003      
CZ-PrNML
005      
20211026133300.0
007      
ta
008      
211013s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/febs.15574 $2 doi
035    __
$a (PubMed)32979285
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Neves, João Filipe $u CNRS ERL9002 Integrative Structural Biology, Lille, France $u Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Risk Factors and Molecular Determinants of Aging-Related Diseases, Univ. Lille, Lille, France
245    10
$a Phosphorylated full-length Tau interacts with 14-3-3 proteins via two short phosphorylated sequences, each occupying a binding groove of 14-3-3 dimer / $c JF. Neves, O. Petrvalská, F. Bosica, FX. Cantrelle, H. Merzougui, G. O'Mahony, X. Hanoulle, T. Obšil, I. Landrieu
520    9_
$a Protein-protein interactions (PPIs) remain poorly explored targets for the treatment of Alzheimer's disease. The interaction of 14-3-3 proteins with Tau was shown to be linked to Tau pathology. This PPI is therefore seen as a potential target for Alzheimer's disease. When Tau is phosphorylated by PKA (Tau-PKA), several phosphorylation sites are generated, including two known 14-3-3 binding sites, surrounding the phosphorylated serines 214 and 324 of Tau. The crystal structures of 14-3-3 in complex with peptides surrounding these Tau phosphosites show that both these motifs are anchored in the amphipathic binding groove of 14-3-3. However, in the absence of structural data with the full-length Tau protein, the stoichiometry of the complex or the interface and affinity of the partners is still unclear. In this work, we addressed these points, using a broad range of biophysical techniques. The interaction of the long and disordered Tau-PKA protein with 14-3-3σ is restricted to two short sequences, containing phosphorylated serines, which bind in the amphipathic binding groove of 14-3-3σ. Phosphorylation of Tau is fundamental for the formation of this stable complex, and the affinity of the Tau-PKA/14-3-3σ interaction is in the 1-10 micromolar range. Each monomer of the 14-3-3σ dimer binds one of two different phosphorylated peptides of Tau-PKA, suggesting a 14-3-3/Tau-PKA stoichiometry of 2 : 1, confirmed by analytical ultracentrifugation. These results contribute to a better understanding of this PPI and provide useful insights for drug discovery projects aiming at the modulation of this interaction.
650    _2
$a proteiny 14-3-3 $x chemie $x genetika $x metabolismus $7 D048948
650    _2
$a Alzheimerova nemoc $x genetika $x metabolismus $x patologie $7 D000544
650    _2
$a vazebná místa $7 D001665
650    _2
$a proteinkinasy závislé na cyklickém AMP $x metabolismus $7 D017868
650    _2
$a exoribonukleasy $x chemie $x genetika $x metabolismus $7 D005095
650    _2
$a lidé $7 D006801
650    _2
$a magnetická rezonanční spektroskopie $7 D009682
650    _2
$a mutace $7 D009154
650    _2
$a fosforylace $7 D010766
650    _2
$a vazba proteinů $7 D011485
650    _2
$a konformace proteinů $7 D011487
650    12
$a multimerizace proteinu $7 D055503
650    _2
$a serin $x chemie $x metabolismus $7 D012694
650    _2
$a povrchová plasmonová rezonance $7 D020349
650    _2
$a proteiny tau $x chemie $x genetika $x metabolismus $7 D016875
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Petrvalská, Olivia $u Department of Structural Biology of Signaling Proteins, Division BIOCEV, Institute of Physiology of the Czech Academy of Sciences, Vestec, Czech Republic $u Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Bosica, Francesco $u Medicinal Chemistry, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden $u Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, The Netherlands
700    1_
$a Cantrelle, François-Xavier $u CNRS ERL9002 Integrative Structural Biology, Lille, France $u Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Risk Factors and Molecular Determinants of Aging-Related Diseases, Univ. Lille, Lille, France
700    1_
$a Merzougui, Hamida $u CNRS ERL9002 Integrative Structural Biology, Lille, France $u Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Risk Factors and Molecular Determinants of Aging-Related Diseases, Univ. Lille, Lille, France
700    1_
$a O'Mahony, Gavin $u Medicinal Chemistry, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
700    1_
$a Hanoulle, Xavier $u CNRS ERL9002 Integrative Structural Biology, Lille, France $u Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Risk Factors and Molecular Determinants of Aging-Related Diseases, Univ. Lille, Lille, France
700    1_
$a Obšil, Tomáš $u Department of Structural Biology of Signaling Proteins, Division BIOCEV, Institute of Physiology of the Czech Academy of Sciences, Vestec, Czech Republic $u Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Landrieu, Isabelle $u CNRS ERL9002 Integrative Structural Biology, Lille, France $u Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Risk Factors and Molecular Determinants of Aging-Related Diseases, Univ. Lille, Lille, France
773    0_
$w MED00008414 $t The FEBS journal $x 1742-4658 $g Roč. 288, č. 6 (2021), s. 1918-1934
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32979285 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133306 $b ABA008
999    __
$a ok $b bmc $g 1714886 $s 1146516
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 288 $c 6 $d 1918-1934 $e 20201010 $i 1742-4658 $m The FEBS journal $n FEBS J $x MED00008414
LZP    __
$a Pubmed-20211013

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...